DiaTech Oncology Receives New York State Clinical Laboratory Permit

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NASHVILLE--(BUSINESS WIRE)--DiaTech Oncology, a life sciences and clinical pathology laboratory company based in Nashville, Tenn., today announced that the company has received a Clinical Laboratory Permit from the New York State Department of Health (NYS DOH). DiaTech’s predictive assay test — which guides the treating oncologist to the most effective chemotherapy for inducing cell death in the malignant cells of a particular cancer patient — is now available to patients and physicians in all 50 states.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC